The evolution of malignant and reactive γδ + T cell clones in a relapse T-ALL case after allogeneic stem cell transplantation
Open Access
- 12 July 2013
- journal article
- research article
- Published by Springer Nature in Molecular Cancer
- Vol. 12 (1) , 73
Abstract
To improve the outcome of patients with T-cell acute lymphoblastic leukemia (T-ALL), characterization of the biological features of T-ALL blast cells and the immune status of patients with T-ALL is needed to identify specific therapeutic strategies. Using a novel approach based on the combination of fine-tiling comparative genomic hybridization (FT-CGH) and ligation-mediated PCR (LM-PCR), we molecularly identified a malignant γδ + T cell clone with a Vδ5Dδ2Jδ1 rearrangement that was paired with a T cell receptor (TCR) VγI and comprised a Vγ1Vδ5 T cell clone in a relapse T-ALL patient. This malignant Vδ5 T cell clone disappeared after chemotherapy, but the clone was detected again when disease relapsed post allogeneic hematopoietic stem cell transplantation (allo-HSCT) at 100 weeks. Using PCR and GeneScan analyses, the distribution and clonality of the TCR Vγ and Vδ subfamilies were examined before and after allo-HSCT in the patient. A reactive T cell clone with a Vδ4Dδ3Jδ1 rearrangement was identified in all samples taken at different time points (i.e., 4, 8, 68, 100 and 108 weeks after allo-HSCT). The expression of this Vδ4+ T cell clone was higher in the patient during complete remission (CR) post allo-HSCT and at disease relapse. This study established a sensitive methodology to detect T cell subclones, which may be used to monitor minimal residual disease and immune reconstitution.Keywords
This publication has 33 references indexed in Scilit:
- In non-transplant patients with multiple myeloma, the pre-treatment level of clonotypic cells predicts event-free survivalMolecular Cancer, 2012
- The role of BCL11B in hematological malignancyExperimental Hematology & Oncology, 2012
- Pediatric T-cell prolymphocytic leukemia with an isolated 12(p13) deletion and aberrant CD117 expressionExperimental Hematology & Oncology, 2012
- Allogeneic hematopoietic stem cell transplantation in China: where we are and where to goJournal of Hematology & Oncology, 2012
- New insights into antigen specific immunotherapy for chronic myeloid leukemiaCancer Cell International, 2012
- Expression and distribution of PPP2R5C gene in leukemiaJournal of Hematology & Oncology, 2011
- Exhaustive T-cell repertoire sequencing of human peripheral blood samples reveals signatures of antigen selection and a directly measured repertoire size of at least 1 million clonotypesGenome Research, 2011
- Generation of diffuse large B cell lymphoma-associated antigen-specific Vα6/Vβ13+T cells by TCR gene transferJournal of Hematology & Oncology, 2011
- Mesenchymal stem cell as salvage treatment for refractory chronic GVHDBone Marrow Transplantation, 2010
- Gene-based outcome prediction in multiple cohorts of pediatric T-cell acute lymphoblastic leukemia: a Children's Oncology Group studyMolecular Cancer, 2010